WebFeb 13, 2024 · SAN DIEGO, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE) today announced the pricing of its previously announced underwritten public offering of 5.0 million shares of its common stock and warrants to purchase up to 3.5 million shares of its common stock. WebJun 30, 2024 · Press Release Daré Bioscience Reports Second Quarter 2024 Financial Results and Provides a Company Update 08-09-2024 at 8:00 AM EDT PDF Version June 30, 2024: $32.1 million in cash and cash equivalents July 2024: approximately $18.0 million in cash received subsequent to quarter-end:
Press Release
WebPress Release. Daré Bioscience Announces Publication in Menopause: The Journal of The North American Menopause Society of Data from Phase 1 Trial of DARE-HRT1 that Support the Potential of DARE ... Web11-50 Employees. Based in San Diego, California. Daré Bioscience is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women’s health. The company’s mission is to … list of welsh cup winners
Press Release - Daré Bioscience
WebOct 17, 2024 · On October 17, 2024, Dare Bioscience, Inc. ("Dare") issued a press release regarding DARE-HRT1, its investigational combination bio-identical 17?-estradiol and bio-identical... WebApr 26, 2024 · SAN DIEGO, April 26, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, today announced that data from the DARE-BVFREE Phase 3 study of DARE-BV1, a thermosetting vaginal gel for the treatment of bacterial vaginosis, will be presented at the 2024 American College of … WebDec 7, 2024 · SAN DIEGO, Dec. 07, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that the U.S. Food and Drug Administration (FDA)... immunotherapy chart